Clark Estates Inc Gsk PLC Transaction History

Clark Estates Inc

$384 Million
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$40.23 - $47.74 $5.03 Million - $5.97 Million	-125,000 Reduced 27.78%	325,000 $14.2 Million
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $3.3 Million - $3.85 Million	-85,000 Reduced 15.89%	450,000 $19.8 Million
Q1 2021 May 14, 2021	BUY	$34.27 - $40.01 $1.71 Million - $2 Million	50,000 Added 10.31%	535,000 $19.1 Million
Q4 2020 Feb 09, 2021	BUY	$34.07 - $39.94 $5.11 Million - $5.99 Million	150,000 Added 44.78%	485,000 $17.8 Million
Q3 2020 Nov 05, 2020	BUY	$38.11 - $42.99 $3.81 Million - $4.3 Million	100,000 Added 42.55%	335,000 $12.6 Million
Q1 2020 Apr 28, 2020	BUY	$32.47 - $48.83 $4.87 Million - $7.32 Million	150,000 Added 176.47%	235,000 $8.9 Million
Q4 2019 Feb 05, 2020	SELL	$42.0 - $48.25 $6.3 Million - $7.24 Million	-150,000 Reduced 63.83%	85,000 $3.99 Million
Q1 2019 May 09, 2019	SELL	$38.57 - $42.69 $3.28 Million - $3.63 Million	-85,000 Reduced 26.56%	235,000 $9.82 Million
Q4 2018 Feb 13, 2019	SELL	$37.8 - $42.69 $3.02 Million - $3.42 Million	-80,000 Reduced 20.0%	320,000 $12.2 Million
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $1.99 Million - $2.13 Million	-50,000 Reduced 11.11%	400,000 $16.1 Million
Q2 2018 Aug 07, 2018	SELL	$39.61 - $42.76 $5.94 Million - $6.41 Million	-150,000 Reduced 25.0%	450,000 $18.1 Million
Q1 2018 Apr 18, 2018	SELL	$36.18 - $40.15 $1.81 Million - $2.01 Million	-50,000 Reduced 7.69%	600,000 $23.4 Million
Q4 2017 Jan 19, 2018	BUY	$35.34 - $41.9 $13.6 Million - $16.1 Million	385,000 Added 145.28%	650,000 $23.1 Million
Q3 2017 Oct 16, 2017	BUY	$39.44 - $41.55 $10.5 Million - $11 Million	265,000	265,000 $10.8 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Estates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Clark Estates Inc with notifications on news.

Account